Study: Stem cell transplants reduce diabetics' insulin reliance

04/14/2009 | Yahoo!

In a U.S. study, 20 of 23 patients with Type 1 diabetes did not need to take daily insulin therapy for four years after receiving transplants of bone marrow-derived stem cells. The study also found that the patients were able to maintain the increase in levels of C-peptides, an indicator for insulin production, for at least three years.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI